
VIDEO – ThreeD Capital $IDK $IDKFF First Monthly NAV Is Just The Beginning Of Exponentially Growing Portfolio $INTL.ca $CRL.ca $WUHN

VIDEO – Valeo Pharma $VPH $VPHIF Hesperco Capsules at Core of Montreal Heart Institute’s Coronavirus Clinical Trial $HLS.ca $MDP.ca $GUD.ca $RX.ca

VIDEO – ORTHO Regenerative Technologies $ORTH.ca $ORTIF is Using Proprietary Tech to Improve Surgery Success Rates and Seize a $5bn Market Opportunity

ORTHO Regenerative Technologies is a cutting-edge med tech firm that uses its proprietary RESTORE technology platform to dramatically improve the success rate of orthopedic and sports medicine surgeries.
- In layman’s terms, that means company has a wonder delivery platform that delivers biologics – drugs made from biological processes – to repair soft tissues in the human body.
The technology uses biologics derived from things like plasma and bone marrow concentrate to regenerate new tissue in various musculoskeletal conditions.
- This includes Wound Healing, Cartilage repair and Osteo-arthritis
So, how big is the market opportunity for Soft Tissue Repair? At least $5bn in the U.S. alone. This includes:
Rotator Cuff TEAR (which leads to shoulder dysfunction and pain):
- 4m patients in the U.S. alone
- 600,000 annual surgeries in the U.S. alone
- $600m+ market opportunity
Meniscus Tear Repair (which is painful and compromises knee function):
- There are 1.2m surgeries annually in U.S. alone
- $1bn+ market opportunity
Cartilage Lesions Repair (this is where lesions cause friction and pain):
- 1.2m detected lesions annually in U.S. alone
- 120,000 surgeries and a lack of options
- $1bn+ market opportunity
Get comfy for this insightful interview with Claude LeDuc, Ortho’s CEO.
California Grants #Cannabis Cultivation License to TransCanna $TCAN.ca $VFF.ca $ACB.ca $GTII.ca $TEQ.ca

Game-changing achievement for the budding cannabis enterprise
- Received a highly coveted cultivation license from the State of California that will accelerate the Company’s cultivation capacity almost immediately
- license represents a major milestone achievement in its endeavors to be California’s leading fully integrated cannabis cultivator, processor, manufacturer, wholesaler and distributor
- “Obtaining this license is a significant turning point for TransCanna and opens up the door to the explosive growth we’ve been positioning ourselves for,” said Bob Blink
Vancouver, British Columbia–(February 20, 2021) – TransCanna Holdings Inc. (CSE: TCAN) (FSE: TH8) (“TransCanna” or the “Company”) is pleased to announce that it has received a highly coveted cultivation license from the State of California that will accelerate the Company’s cultivation capacity almost immediately.
The State of California has granted a cultivation license to Lyfted Farms – a TransCanna wholly owned subsidiary – for its flagship Daly facility in Modesto, California. Bob Blink, TransCanna CEO states “Such cultivation licenses in the region are notoriously difficult to obtain. Current applications are back-logged and not even being considered for processing by the county until the end of 2021.”
For TransCanna, the license represents a major milestone achievement in its endeavors to be California’s leading fully integrated cannabis cultivator, processor, manufacturer, wholesaler and distributor.
“Obtaining this license is a significant turning point for TransCanna and opens up the door to the explosive growth we’ve been positioning ourselves for,” said Bob Blink. “Demand has been consistently outstripping supply for our exotic indoor cannabis strains, and now with this new massive facility receiving approval for cultivation, we can finally meet that demand and continue to scale. This will make us one of the largest licensed facilities of its kind in the State of California.”
In addition to cultivation, the new Daly facility empowers TransCanna to increase its scope of offerings and establish its dominance in the California cannabis supply chain.
The Daly facility will anchor other TransCanna operations and serve as a supply chain hub for third party farms across Northern California, offering secure storage, concentrate manufacturing, wholesale market-making, white label services, and State-wide distribution.
Prior to achieving its cultivation license, the facility gained its distribution license in June 2020. Next, TransCanna is eagerly anticipating its processing license (pending approval by the State of California mid to late March) which will qualify the company to dry, cure, trim, grade, and package cannabis onsite. In addition to saving time and money for in-house brands with on-site processing, the processing license will enable TransCanna to open up new revenue streams servicing third party growers.
“California’s cannabis market is $5 billion in sales and growing, and we are well on our way to establishing ourselves at the epicenter of this category with our cultivation, processing, wholesaling and distribution arms of the entire California supply chain,” said Bob Blink, TransCanna CEO.
About TransCanna
TransCanna Holdings Inc. is a California-based, Canadian-listed company building cannabis-focused brands for the California lifestyle, through its wholly-owned California subsidiaries.
TransCanna’s wholly owned subsidiary Lyfted Farms is California’s authentic cannabis brand whose pioneering spirit has been continuously providing the finest cannabis flower genetics and cultivation methods since 1984. The Lyfted Farms brand of exclusive cannabis flower is sold at premium retailers throughout the state. With its new cultivation facility in Daly, California, the company is now poised to become one of the largest and most efficient vertically integrated cannabis companies in the California market.
Read more: https://agoracom.com/ir/TranscannaHoldings/forums/discussion/topics/755740-california-grants-cannabis-cultivation-license-to-transcanna/messages/2304595#message
@Novamind_Inc $NM.ca $NVMDF Weekly Roundup $RVV.ca $MMED $PSYC.ca $FTRP.ca $CMPS $NUMI.ca



A weekly summary of Novamind news and media


FEATURES February 19, 2021
Dr. Reid Robison on Our Purpose-Driven Mission to Help People who are Suffering
Agoracom interviewed our Chief Medical Officer about our latest expansions, the striking results from treatments, and what it takes to build infrastructure for psychedelic-assisted healthcare.
FEATURES February 18, 2021
Novamind Leading the Charge to Deliver Mental Health Alternatives
Psychedelic Invest published an article about the urgent need for innovative mental health treatments, and the companies working to meet that need.


Novamind Announces Symbol Change on OTC Market To “NVMDF”
February 19, 2021


Follow @novamind_inc on Instagram



Novamind is a leading mental health company enabling safe access to psychedelic medicine through a network of clinics, retreats, and clinical research sites. Novamind provides ketamine-assisted psychotherapy and other novel treatments through its network of Cedar Psychiatry clinics and operates Cedar Clinical Research, a contract research organization specialized in clinical trials and evidence-based research for psychedelic medicine. Both Cedar Psychiatry and Cedar Clinical Research are wholly-owned subsidiaries of Novamind. For more information on how Novamind is enhancing mental wellness and guiding people through their entire healing journey, visit www.novamind.ca
Following E-Commerce Launch, TAAT™ $TAAT.ca $TOBAF Sells More than CAD $50,000 of Product in 48 Hours
- Orders placed through the TAAT™ online store shipped to 20 different U.S. states
- The average order had a value of approximately USD $57
- The average order size was 1.7 cartons

LAS VEGAS and VANCOUVER, British Columbia, Feb. 19, 2021 — TAAT ™ LIFESTYLE & WELLNESS LTD. (CSE: TAAT) (OTCQB: TOBAF) (FRANKFURT: 2TP2) (the “Company” or “TAAT ™ ”) is pleased to announce strong sales performance following the launch of its e-commerce portal earlier this week.
In addition to the launch of the TAAT™ online store, the Company has continued to add new retail points of sale for TAAT™ in the state of Ohio, as shown on the maps in this press release, with significant increases in areas to include Cincinnati (population 301,000) and Columbus (population 878,000).
Additionally, nationwide campaigns led by a consumer packaged goods (“CPG”) sales agency who directly services over 100,000 convenience stores in the United States are set to begin next week and will run concurrently with marketing efforts for the TAAT™ online store.
Orders placed through the TAAT™ online store had shipping addresses in 20 different U.S. states, with an average order value of approximately USD $57.00 and an average order size of 1.7 cartons.
Predictiv AI $PAI.ca $INOTF Signs SISCO to Distribute Thermalpass to Its U.S. Customer Base
- $PAI.ca’s ThermalPass will be paired with the SISCO Fast-Pass® Visitor Management System
- The paired tech will assist with track-and-trace efforts and provide peace of mind to building occupants and visitors
TORONTO , Feb. 19, 2021 – Predictiv AI Inc. (TSX-V: PAI) (OTC: INOTF) (FSE: 71TA) (” Predictiv AI ” or the ” Company “), www.predictiv.ai , a software and solutions provider in the artificial intelligence markets is pleased to announce that Security Identification Systems Corp. (SISCO) , www.siscocorp.com , has joined ThermalPass as a channel reseller and distributor to market and sell the ThermalPass to its U.S. customers in hospitality, healthcare, commercial enterprises and government.
ThermalPass will be paired with the SISCO Fast-Pass® Visitor Management System to assist with track-and-trace efforts and to provide enhanced peace of mind to building occupants and visitors.
Since 1994, SISCO has been dedicated to developing best-in-class visitor management solutions for confirming credentials and tracking people for public and private entities. Fully-compliant with the various legislation throughout the United States , SISCO provides world-class security products and services using state-of-the-art technologies and integrated security solutions.
“The seamless integration of ThermalPass’ technology allows us to immediately offer the new solution to all of our existing clients including Royal Caribbean International, Norwegian Cruise Line, Princess Cruises, Shriners International, Cleveland Clinic, HCA Healthcare, NYPD, Palm Beach Police Department, Miami Police Department, PPG Industries, J.W. Marriott, and many others,” said SISCO CEO Anthony Zagami.
“Because ThermalPass is a touchless screening device that operates much like a metal detector, taking multiple temperature readings instantaneously, when coupled with Fast-Pass, it immediately provides front-line workers with the necessary data and insight in handling high volumes of people entering facilities. This allows practitioners to respond accordingly with their organization’s standard operating procedures, and in real time.”
@Novamind_Inc $NM.ca Announces Symbol Change on OTC Market To $NVMDF $RVV.ca $MMED $PSYC.ca $FTRP.ca $CMPS $NUMI.ca

- To commence trading on the OTC Pink Market under the symbol “NVMDF” effective February 19, 2021.
- The Company’s common shares will continue to trade on the Canadian Securities Exchange under the symbol “NM”.
TORONTO, ON / ACCESSWIRE / February 19, 2021 / Novamind Inc., (CSE:NM)(OTC PINK:NVMDF) (“Novamind” or the “Company”) a mental health company specialized in psychedelic medicine, announces that its common shares, previously listed for trading on the OTC Pink Market in the United States under the symbol “HNLMF”, are to commence trading on the OTC Pink Market under the symbol “NVMDF” effective February 19, 2021. The Company’s common shares will continue to trade on the Canadian Securities Exchange under the symbol “NM”.
Novamind intends to apply to list its common shares on the OTCQB Market in the near future. The OTCQB Market is an established financial market in the United States for promising, investor-focused companies based in America or internationally.
About Novamind
Novamind is a leading mental health company enabling safe access to psychedelic medicine through a network of clinics, retreats, and clinical research sites. Novamind provides ketamine-assisted psychotherapy and other novel treatments through its network of Cedar Psychiatry clinics and operates Cedar Clinical Research, a contract research organization specialized in clinical trials and evidence-based research for psychedelic medicine. Both Cedar Psychiatry and Cedar Clinical Research are wholly-owned subsidiaries of Novamind. For more information on how Novamind is enhancing mental wellness and guiding people through their entire healing journey, visit www.novamind.ca.
Read more: https://agoracom.com/ir/Novamind/forums/discussion/topics/755663-novamind-announces-symbol-change-on-otc-market-to-nvmdf/messages/2304371#message
VIDEO – @goplantx $VEGA $PLTXF is the One-Stop-Shop for Everything Plant-Based $VERY.ca $MEAT.ca $EATS.ca $VEGN.ca

Valeo Pharma $VPH $VPHIF to Report Fourth Quarter and 2020 Year-End Results and Hold Investors Conference Call / Webcast $HLS.ca $MDP.ca $GUD.ca $RX.ca

- Valeo will host a conference call to discuss those results and highlights on Thursday February 25, 2021 at 8.30am (EST) .
- The telephone numbers to access the conference call are 1-888-231-8191 and 647-427-7450.
MONTREAL , Feb. 19, 2021 – Valeo Pharma Inc . (CSE: VPH) (OTCQB: VPHIF) (FSE: VP2) (” Valeo ” or the ” Company “), a Canadian specialty pharmaceutical company, announced today that it will report its financial results and highlights for the fourth quarter and year ended October 31, 2020 on Wednesday February 24, 2021 after market close.
Valeo will host a conference call to discuss those results and highlights on Thursday February 25, 2021 at 8.30am (EST) . The telephone numbers to access the conference call are 1-888-231-8191 and 647-427-7450. An audio replay of the call will be available. The numbers to access the audio replay are 1-855-859-2056 and 416-849-0833 using the following access code (1498873).
A live audio webcast of the conference call will be available via: https://produceredition.webcasts.com/starthere.jsp?ei=1433860&tp_key=71fe5003d2





